+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infectious Disease Drug"

Human Papillomavirus Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Human Papillomavirus Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • July 2022
  • 452 Pages
  • Global
From
Epstein-Barr Virus (HHV-4) Infections - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Epstein-Barr Virus (HHV-4) Infections - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 136 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • November 2023
  • 270 Pages
  • Global
From
Pseudomonas aeruginosa Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Pseudomonas aeruginosa Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • May 2022
  • 153 Pages
  • Global
From
Clostridioides difficile Infections (Clostridium difficile Associated Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Clostridioides difficile Infections (Clostridium difficile Associated Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • May 2022
  • 257 Pages
  • Global
From
Hepatitis D Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hepatitis D Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 71 Pages
  • Global
From
Genital Herpes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Genital Herpes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 86 Pages
  • Global
From
Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 65 Pages
  • Global
From
Glycoprotein 41 (gp41) - Pipeline Review, H2 2020 - Product Thumbnail Image

Glycoprotein 41 (gp41) - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 65 Pages
  • Global
From
Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 57 Pages
  • Global
From
Genital Herpes - Pipeline Review, H2 2020 - Product Thumbnail Image

Genital Herpes - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 123 Pages
  • Global
From
Bacterial Vaginosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Bacterial Vaginosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 75 Pages
  • Global
From
Toxoplasmosis - Pipeline Review, H1 2020 - Product Thumbnail Image

Toxoplasmosis - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 48 Pages
  • Global
From
Anti-infectious Disease Drugs Companies in China - Product Thumbnail Image

Anti-infectious Disease Drugs Companies in China

  • Report
  • August 2024
  • 86 Pages
  • China
From
Anti-Infectious Disease Drugs Markets in China - Product Thumbnail Image

Anti-Infectious Disease Drugs Markets in China

  • Report
  • August 2024
  • 229 Pages
  • China
From
Infectious Disease Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Infectious Disease Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • May 2023
  • 116 Pages
  • Global
From
Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 69 Pages
  • Global
From
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 34 Pages
  • Global
From
Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 94 Pages
  • Global
From
Influenza A Virus, H7N9 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Influenza A Virus, H7N9 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Infectious Disease Drug market is a subset of the pharmaceutical industry that focuses on the development and production of drugs to treat infectious diseases. These drugs are used to treat a wide range of illnesses, from bacterial and viral infections to fungal and parasitic diseases. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. They also work to ensure that their drugs are safe and effective. Some of the major players in the Infectious Disease Drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Johnson & Johnson, and AstraZeneca. These companies are involved in the research, development, and production of drugs to treat a variety of infectious diseases. Show Less Read more